Primary peritoneal carcinosarcoma (malignant mixed mullerian tumor): Report of a case with five-year disease free survival after surgery and chemoradiation and a review of literature

References

• Shen DH, Khoo US, Xue WC, Ngan HY, Wang JL, Liu VW, et al. Primary peritoneal malignant mixed mullerian tumors. A clinicopathologic, immunohistochemical and genetic study. Cancer 2001; 91: 1052–60
   PubMed Web of Science ®Google Scholar
• Dincer AD, Timmins P, Pietrocola D, Fisher H, Ambros RA. Primary peritoneal mullerian adenosarcoma with sarcomatous overgrowth associated with endometriosis: a case report. Int J Gynecol Patho 2001; 21: 65–8
   Web of Science ®Google Scholar
• Garamvoelgyi E, Guillou L, Gebhard S, Salmeron M, Seematter RJ, Hadji MH. Primary malignant mixed mullerian tumor (metaplastic carcinoma) of the female peritoneum. A clinical, pathologic, and immunohistochemical study of three cases and a review of literature. Cancer 1994; 74: 854–63
   PubMed Web of Science ®Google Scholar
• Wei L, Wang J, Zhang X, Cui H, Shen D, Qian H. Primary omental malignant mixed mullerian tumor in a 67-year-old woman. Chin Med J 2002; 115: 138–40
   PubMed Web of Science ®Google Scholar
• Garde JR, Jones MA, McAfee R, Tarraza HM. Extragenital malignant mixed mullerian tumor: review of literature. Gynecol Oncol 1991; 43: 186–90
   PubMed Web of Science ®Google Scholar
• Parker RL, Dadmanesh F, Young RH, Clement PB. Polypoid endometriosis. A clinicopathologic analysis of 24 cases and a review of the literature. Am J Surg Pathol 2004; 28: 285–97
   PubMed Web of Science ®Google Scholar
• Mira JL, Fenoglio-Preiser CM, Husseinzadeh N. Malignant mixed mullerian tumor of the extraovarian secondary mullerian system. Report of two cases and review of English literature. Arch Pathol Lab Med 1995; 119: 1044–9
   PubMed Web of Science ®Google Scholar
• Sumathi VP, Murnaghan M, Dobbs P, McCluggage WG. Extragenital Mullerian carcinosarcoma arising from the peritoneum: report of two cases. Int J Gynecol Cancer 2002; 12: 164–7
   Web of Science ®Google Scholar
• McCluggage WC. Malignant biphasic uterine tumors: carcinosarcomas or metastatic carcinomas?. J Clin Pathol 2002; 55: 321–5
   PubMed Web of Science ®Google Scholar
• Shintaku M, Matsumoto T. Primary Mullerian carcinosarcoma of the peritoneum: report of a case. Int J Gynecol Pathol 2001; 20: 191–5
   PubMed Web of Science ®Google Scholar
• Chen KT, Wolk RW. Extragenital malignant mixed mullerian tumor. Gynecol Oncol. 1988; 30: 422–6
   PubMed Web of Science ®Google Scholar
• Rose PG, Rodriguez M, Abdul-Karim FW. Malignant mixed mullerian tumor of the female peritoneum: treatment and outcome of three cases. Gynecol Oncol 1997; 65: 523–5
   PubMed Web of Science ®Google Scholar
• Thigpen JT, Blessing JA, Beecham J, Homesley H, Yordan E. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study. J Clin Oncol 1991; 9: 1962–6
   PubMed Web of Science ®Google Scholar
• Topuz E, Eralp A, Aydiner A, Saip P, Tas F, Yavuz E, et al. The role of chemotherapy in malignant mixed tumors of the female genital tract. Eur J Gynecol Oncol 2001; 22: 469–72
   PubMed Web of Science ®Google Scholar
• Inthasorn P, Carter J, Valmadre S, Beale P, Russel P, Dalrymple C. Analysis of clinicopathologic factors in malignant mixed Mullerian tumors of the uterine corpus. Int J Gynecol Cancer 2002; 12: 348–53
   PubMed Web of Science ®Google Scholar
• Arrastia C, Fruchter R, Clark M, Maiman M, Remy JC, Macasaet M, et al. Uterine carcinosarcomas. Incidence and trends in management and survival. Gynecol Oncol 1997; 65: 158–63
   PubMed Web of Science ®Google Scholar
• Callister M, Ramondetta LM, Jhingran A, Burke TW, Eifel PJ. Malignant mixed Mullerian tumors of the uterus: Analysis patterns of failure, prognostic factors and treatment outcome. Int J Radiat Oncol Biol Phys 2004; 58: 786–96
   PubMed Web of Science ®Google Scholar
• Goshen R, Chu W, Elit L, Pal T, Hakimi J, Ackerman I, et al. Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?. Gynecol Oncol 2000; 79: 477–81
   PubMed Web of Science ®Google Scholar
• Menczer J, Chetrit A, Barda G, Lubin F, Fishler Y, Sltaras M, et al. Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish women. Gynecol Oncol 2003; 88: 58–61
   PubMed Web of Science ®Google Scholar
• Khoo US, Ngan HY, Cheung AN, Chan KY, Lu J, Chan VW, et al. Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations. Hum Mutat 2000; 16: 88–9
   PubMedGoogle Scholar